BlackRock’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $25K | Sell |
|
|||||
|
2022
Q4 | $54.6K | Sell |
|
|||||
|
2022
Q3 | $92K | Sell |
|
|||||
|
2022
Q2 | $91K | Buy |
|
|||||
|
2022
Q1 | $163K | Buy |
|
|||||
|
2021
Q4 | $113K | Buy |
|
|||||
|
2021
Q3 | $219K | Buy |
|
|||||
|
2021
Q2 | $247K | Sell |
|
|||||
|
2021
Q1 | $397K | Buy |
|
|||||
|
2020
Q4 | $366K | Buy |
|
|||||
|
2020
Q3 | $674K | Sell |
|
|||||
|
2020
Q2 | $772K | Buy |
|
|||||
|
2020
Q1 | $474K | Sell |
|
|||||
|
2019
Q4 | $1.3M | Sell |
|
|||||
|
2019
Q3 | $1.06M | Sell |
|
|||||
|
2019
Q2 | $2.15M | Sell |
|
|||||
|
2019
Q1 | $9.69M | Sell |
|
|||||
|
2018
Q4 | $8.57M | Sell |
|
|||||
|
2018
Q3 | $21.1M | Buy |
|
|||||
|
2018
Q2 | $23M | Buy |
|
|||||
|
2018
Q1 | $14.8M | Sell |
|
|||||
|
2017
Q4 | $19.5M | Sell |
|
|||||
|
2017
Q3 | $27.2M | Buy |
|
|||||
|
2017
Q2 | $25.7M | Buy |
|
|||||
|
2017
Q1 | $20.6M | Buy |
|
|||||
|
2016
Q4 | $35K | Buy |
|
|||||
|
2016
Q3 | $47K | Buy |
|
|||||
|
2016
Q2 | $28K | Buy |
|
|||||
|
2016
Q1 | $3K | Buy |
|
|||||
|
2015
Q4 | $4K | Sell |
|
|||||
|
2015
Q3 | $26K | Buy |
|
|||||
|
2015
Q2 | $4K | Hold |
|
|||||
|
2015
Q1 | $5K | Buy |
|